Your browser doesn't support javascript.
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests for people with suspected COVID-19 in the community.
Stohr, Joep J J M; Zwart, Vivian F; Goderski, Gabriel; Meijer, Adam; Nagel-Imming, Carla R S; Kluytmans-van den Bergh, Marjolein F Q; Pas, Suzan D; van den Oetelaar, Femke; Hellwich, Marloes; Gan, Kim H; Rietveld, Ariene; Verweij, Jaco J; Murk, Jean-Luc; van den Bijllaardt, Wouter; Kluytmans, Jan A J W.
  • Stohr JJJM; Department of Infection Control, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands. Electronic address:
  • Zwart VF; Department of Infection Control, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
  • Goderski G; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Meijer A; National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Nagel-Imming CRS; Department of Infection Control, Amphia Hospital, Breda, the Netherlands.
  • Kluytmans-van den Bergh MFQ; Department of Infection Control, Amphia Hospital, Breda, the Netherlands; Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands; Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Pas SD; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
  • van den Oetelaar F; Municipal Health Services GGD Hart voor Brabant, 's-Hertogenbosch, the Netherlands.
  • Hellwich M; Municipal Health Services GGD Hart voor Brabant, 's-Hertogenbosch, the Netherlands.
  • Gan KH; Municipal Health Services GGD Hart voor Brabant, 's-Hertogenbosch, the Netherlands.
  • Rietveld A; Municipal Health Services GGD Hart voor Brabant, 's-Hertogenbosch, the Netherlands.
  • Verweij JJ; Microvida Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
  • Murk JL; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands.
  • van den Bijllaardt W; Department of Infection Control, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands.
  • Kluytmans JAJW; Department of Infection Control, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands; Microvida Laboratory for Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands; Amphia Academy Infe
Clin Microbiol Infect ; 28(5): 695-700, 2022 May.
Article in English | MEDLINE | ID: covidwho-1340599
ABSTRACT

OBJECTIVES:

To evaluate the performance of nasal mid-turbinate self-testing using rapid antigen detection tests (RDT) for persons with suspected coronavirus disease 2019 (COVID-19) in the community. Self-testing for COVID-19 infection with lateral flow assay severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RDT, provides rapid results and could enable frequent and extensive testing in the community, thereby improving the control of SARS-CoV-2.

METHODS:

Participants visiting a municipal SARS-CoV-2 testing centre, received self-testing kits containing either the BD Veritor System (BD-RDT) or Roche SARS-CoV-2 antigen detection test (Roche-RDT). Oro-nasopharyngeal swabs were collected from the participants for quantitative RT-PCR (qRT-PCR) testing. As a proxy for contagiousness, viral culture was performed on a selection of qRT-PCR positive samples to determine the Ct-value at which the chance of a positive culture dropped below 0.5 (Ct-value cut-off). Sensitivity and specificity of self-testing were compared to qRT-PCR with a Ct-value below the Ct value cut-off. Determinants independently associated with a false-negative self-test result were determined.

RESULTS:

A total of 3201 participants were included (BD-RDT n = 1595; Roche-RDT n = 1606). Sensitivity and specificity of self-testing compared with the qRT-PCR results with a Ct-value below the Ct-value cut-off were 78.4% (95% CI 73.2%-83.5%) and 99.4% (95% CI 99.1%-99.7%), respectively. A higher age was independently associated with a false-negative self-testing result with an odds ratio of 1.024 (95% CI 1.003-1.044).

CONCLUSIONS:

Self-testing using currently available RDT has a high specificity and relatively high sensitivity to identify individuals with a high probability of contagiousness.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2022 Document Type: Article